Context Therapeutics Inc. CNTX Q4 2025 Annual earnings
Reported March 19, 2026 · Before market open
EPS-$0.14Miss by $0.03
Revenue estimate-$1.5M
EPS estimate-$0.11
Next report
Aug 5, 2026 (In 1 week)EPS estimate-$0.10
Versus estimates
Diluted EPS
Ask the moment Context Therapeutics Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Context Therapeutics Inc. report Q4 2025 earnings?
- Context Therapeutics Inc. (CNTX) reported Q4 2025 earnings on March 19, 2026 before market open.
- What were Context Therapeutics Inc.'s Q4 2025 revenue and EPS?
- Context Therapeutics Inc. reported eps of $-0.14 for Q4 2025.
- Did Context Therapeutics Inc. beat estimates in Q4 2025?
- EPS missed the consensus estimate of $-0.11 by $0.03.
- How did Context Therapeutics Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 250.0% from $-0.04.
- Where can I find Context Therapeutics Inc.'s Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001628280-26-020498) directly on SEC EDGAR. The filing index links above go to sec.gov.